| 68.42 Data as of May 17 |  +0.73 / +1.08%Today’s Change | 43.96 Today|||52-Week Range 69.25 | +24.97% Year-to-Date |
| What West Pharmaceutical Services's Earnings Headlines Didn't Tell You May 17 / MotleyFool.com | HSIC Misses Earnings Despite Y/Y Gain - Analyst Blog May 08 / Zacks.com |
| Previous close | 67.69 |
| Today’s open | 67.71 |
| Day’s range | 67.43 - 68.51 |
| Volume | 140,944 |
| Average volume (3 months) | 118,835 |
| Market cap | $2.4B |
| Dividend yield | 1.11% |
| Earnings growth (last year) | +6.48% |
| Earnings growth (this year) | +13.77% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | +6.19% |
| P/E ratio | 28.7 |
| Price/Sales | 1.47 |
| Price/Book | 3.22 |
| Today’s change | Today’s % change | |
|---|---|---|
| HAEHaemonetics Corp | +1.25 | +3.13% |
| PODDInsulet Corp | +0.42 | +1.44% |
| DXCMDexCom Inc | +1.73 | +8.89% |
| GMEDGlobus Medical Inc | +0.19 | +1.23% |
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | $0.82 |
| Annual revenue (last year) | $1.3B |
| Annual profit (last year) | $80.7M |
| Net profit margin | 6.37% |
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer Donald E. Morel, Jr., PhD |
Chief Financial Officer & Vice President William J. Federici, MBA, CPA |
Corporate headquarters Exton, Pennsylvania |
.
